webinar register page

Clinical Genetic Testing for Parkinson’s Disease: Why, When and How?
Part Two of a Two-Part Virtual CME Series:
Enabling Genetically Targeted Therapeutics in Parkinson’s Disease

This program will provide a more in-depth review of the current understanding of the role of genetics in pathogenesis of Parkinson’s disease (PD) and focus on the implications of recent discoveries on clinical research. Specifically, the program will cover the current understanding of the role of the lysosomal pathway in pathogenesis of sporadic and genetic forms of PD, review the genetically targeted clinical trials in PD and discuss mechanisms for genotyping of PD patients (including direct to consumer, research and commercial testing) as well as the role of genetic counseling.

Feb 25, 2021 05:00 PM in Central Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Sarah Baggs.